Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AstraZeneca PLC Faces Class Action Lawsuit Deadline for Stockholders: Robbins LLP Issues Reminder

January 15, 2025
Robbins LLP, a global investor rights law firm, is reminding stockholders of AstraZeneca PLC (AZN) about the upcoming lead plaintiff deadline in the class action lawsuit against the company. The deadline, which is fast approaching, provides an opportunity for investors to take legal action if they have suffered significant losses.

The lawsuit alleges that AstraZeneca PLC made false and misleading statements regarding the efficacy and safety of its COVID-19 vaccine. These alleged misrepresentations caused the company's stock price to artificially inflate, leading to financial harm for investors.

The class action lawsuit seeks to recover damages for stockholders who purchased AstraZeneca PLC's securities between May 21, 2020, and November 20, 2021. Investors who believe they may be eligible to lead the class action lawsuit are encouraged to contact Robbins LLP for more information.

While the class action lawsuit poses a potential legal risk to AstraZeneca PLC, the company remains an attractive option for long-term growth. With its innovative drug pipeline and strong market presence, AstraZeneca is positioned to capitalize on emerging healthcare trends and market demands.

For investors looking to navigate the complexities of the stock market, seeking professional guidance from experts such as Stocks Prognosis can provide valuable insights and forecasts. Consulting with professionals who specialize in stock analysis and forecasting can help investors make informed decisions and mitigate risks.

Disclaimer: This news article does not provide any financial advice or recommendations to buy or sell stocks. It is important to conduct thorough research and seek professional advice before making any investment decisions.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNAugust 25, 2025AstraZeneca's Breakthrough Study on Advanced Biliary Tract Cancer  ~1 min.

AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....


AZNAugust 22, 2025ASTRAZENECA PLC Hits Price Target Forecast with 20.55% Profit  ~1 min.

On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....


AZNAugust 22, 2025ASTRAZENECA PLC Stock Hits QuantWave's Price Target Forecast with 14.63% Profit  ~1 min.

ASTRAZENECA PLC stock has successfully reached the price target forecast provided by QuantWave, resulting in a profitable outcome for investors....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Yielding 14.58% Profit - QuantWave Prediction Success  ~2 min.

On June 18, 2025, QuantWave issued a long forecast signal for ASTRAZENECA PLC when the stock was trading at $70.27....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with 16.44% Profit: A Win for QuantWave  ~1 min.

ASTRAZENECA PLC, one of the leading pharmaceutical companies, has seen its stock price hit the forecasted target with a substantial 16....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Generating 13.99% Profit for QuantWave Users  ~2 min.

On July 2, 2025, QuantWave, an automated forecasting platform, issued a price target forecast for ASTRAZENECA PLC with a long signal at a price of 70.64 $....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with a 15.91% Profit  ~1 min.

QuantWave's forecast signal for ASTRAZENECA PLC on June 20, 2025, proved to be accurate as the stock reached the predicted target on August 20, 2025. The price at the time of the signal was 69....


AZNAugust 20, 2025ASTRAZENECA PLC Hits QuantWave Forecast Target with 15.71% Profit  ~1 min.

On June 26, 2025, QuantWave's automated forecasting platform issued a long signal for ASTRAZENECA PLC with a price target of $80.52. The stock was trading at $69....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Forecast Price Target with Profit of 13.46%: QuantWave Analysis  ~2 min.

ASTRAZENECA PLC's stock recently achieved the price target forecasted by QuantWave with a profit of 13.46%....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with 16.75% Profit  ~1 min.

On July 3, 2025, QuantWave's forecast signal indicated a long position for ASTRAZENECA PLC when the stock was priced at 68.97 $. Today, on August 20, 2025, the price of ASTRAZENECA PLC reached 80....


AZNJanuary 9, 2025The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline in AstraZeneca PLC Lawsuit  ~1 min.

AstraZeneca PLC (NASDAQ: AZN) recently faced a class action lawsuit, and The Gross Law Firm is reminding shareholders about an upcoming lead plaintiff deadline of February 21, 2025....


EIXFebruary 24, 2025Edison International Faces Lawsuit from Stockholders  ~1 min.

Robbins LLP, a renowned law firm, has reminded investors of Edison International (EIX) who have experienced significant losses that the company is currently facing a lawsuit filed by stockholders....


AZNNovember 24, 2024AstraZeneca PLC Receives Acquisition Offer from Pathstone Holdings LLC  ~1 min.

Pathstone Holdings LLC has announced its intention to acquire AstraZeneca PLC, a leading pharmaceutical company specializing in immunotherapy....


MUFebruary 24, 2025MU STOCK NEWS: Robbins LLP Reminds Micron Technology Inc. Investors of the Pending Lead Plaintiff Deadline  ~1 min.

A class action lawsuit has been filed against Micron Technology Inc. on behalf of investors who purchased the company's securities between March 10, 2025....


AZNNovember 7, 2024AstraZeneca PLC Facing China Probe Risks, Shares Drop  ~1 min.

Are Options Traders Betting on a Big Move in AstraZeneca AZN Stock? Yahoo Finance reported that AstraZeneca PLC (AZN) is facing potential risks from a China probe, causing its shares to drop....